{
    "Trade/Device Name(s)": [
        "Diazyme HDL-Cholesterol Reagent"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "K072395",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021316"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LBS",
        "JJX"
    ],
    "Summary Letter Date": "January 3, 2008",
    "Summary Letter Received Date": "December 27, 2007",
    "Submission Date": "December 21, 2007",
    "Regulation Number(s)": [
        "21CFR862.1475"
    ],
    "Regulation Name(s)": [
        "High Density Lipoprotein Cholesterol Test"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "High Density Lipoprotein Cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Modified PVS/PEGME precipitation",
        "Trinder reaction"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme HDL-Cholesterol Reagent for quantitative in vitro determination of HDL cholesterol in serum or plasma",
    "Indications for Use Summary": "For the in vitro quantitative determination of High Density Lipoprotein Cholesterol in human serum or plasma to assist in diagnosis and treatment of patients at risk for coronary heart disease",
    "fda_folder": "Clinical Chemistry"
}